Local Substudy Associated to the International Study MO19390 to Determine the BRCA1 Gene mRNA Expression as a Predictive Marker of Response to Chemotherapy
Interventional
Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Progression-free survival
Event driven
No
Clinical Trials
Study Director
Hoffmann-La Roche
Spain: Ministry of Health
ML21150
NCT00642824
May 2007
December 2009
Name | Location |
---|